Article citationsMore>>

Nghiem, P., Bhatia, S., Lipson, E.J., Sharfman, W.H., Kudchadkar, R.R., Brohl, A.S., et al. (2021) Three-Year Survival, Correlates and Salvage Therapies in Patients Receiving First-Line Pembrolizumab for Advanced Merkel Cell Carcinoma. Journal for ImmunoTherapy of Cancer, 9, e002478.
https://doi.org/10.1136/jitc-2021-002478

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top